Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;30(7):918-926.
doi: 10.1016/j.jsps.2022.04.013. Epub 2022 Apr 30.

A review on benefits of quercetin in hyperuricemia and gouty arthritis

Affiliations
Review

A review on benefits of quercetin in hyperuricemia and gouty arthritis

Thanutchaporn Nutmakul. Saudi Pharm J. 2022 Jul.

Abstract

Hyperuricemia becomes a public health problem worldwide. It is not only a major risk factor for gout but also associated with the development of life-threatening diseases such as chronic kidney disease and cardiovascular diseases. Although there are several available therapeutic drugs, some serious adverse effects and contraindications are concerned. These drive the search for an alternative therapy that is effective and safe. Quercetin is of particular interesting since it has been reported numerous pharmacological activities, especially anti-hyperuricemia, antioxidant, anti-inflammation and amelioration of metabolic syndromes and cardiovascular diseases which are comorbidities of hyperuricemia and gout. In addition, quercetin has been widely used as a health supplement for many diseases however, the use for hyperuricemia and gout has not been indicated. Therefore, this review aims to gather and summarize published data regarding the efficacy in preclinical and clinical studies along with possible mechanism of action, and safety aspect of quercetin in order to support the use of quercetin as a dietary supplement for prevention and management of hyperuricemia and gouty arthritis and/or use as alternative or combination therapy to minimize the side effects of the conventional drugs.

Keywords: Antioxidant; Gout; Hyperuricemia; NLRP3 inflammasome; Quercetin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Chemical structure of quercetin.
Fig. 2
Fig. 2
Urate production and excretion in human body. 5′NT, 5′-nucleotidase; ADA, adenosine deaminase; AMPD, AMP deaminase; KHK, ketohexokinase; PNP, purine nucleoside phosphorylase; XO, xanthine oxidase; XDH, xanthine dehydrogenase.
Fig. 3
Fig. 3
NLRP3 inflammasome priming and activation in gouty arthritis.

References

    1. Adachi S.-I., Oyama M., Kondo S., Yagasaki K. Comparative effects of quercetin, luteolin, apigenin and their related polyphenols on uric acid production in cultured hepatocytes and suppression of purine bodies-induced hyperuricemia by rutin in mice. Cytotechnology. 2021;73(3):343–351. doi: 10.1007/s10616-021-00452-9. - DOI - PMC - PubMed
    1. Anand David A.V., Arulmoli R., Parasuraman S. Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacogn. Rev. 2016;10:84–89. doi: 10.4103/0973-7847.194044. - DOI - PMC - PubMed
    1. Andres S., Pevny S., Ziegenhagen R., Bakhiya N., Schäfer B., Hirsch-Ernst K.I., Lampen A. Safety aspects of the use of quercetin as a dietary supplement. Mol. Nutr. Food Res. 2018;62(1):1700447. doi: 10.1002/mnfr.201700447. - DOI - PubMed
    1. Bardin T., Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017;15:123. doi: 10.1186/s12916-017-0890-9. - DOI - PMC - PubMed
    1. Battelli M.G., Polito L., Bortolotti M., Bolognesi A. Xanthine oxidoreductase-derived reactive species: physiological and pathological effects. Oxid. Med. Cell. Longev. 2016;2016:1–8. doi: 10.1155/2016/3527579. - DOI - PMC - PubMed

LinkOut - more resources